MedPath

comparing effect of dexmedetomidine versus dexamethasone as an adjuvant with ropivacaine in blocks for thyroid surgeries

Not Applicable
Conditions
Health Condition 1: O- Medical and Surgical
Registration Number
CTRI/2021/05/033720
Lead Sponsor
JLN medical college Ajmer
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients undergoing thyroid surgery under general anaesthesia

Patient age between 16 â?? 60 years

ASA physical status I and II

Exclusion Criteria

Age < 16 and > 60 years

ASA physical status III, IV, V and VI.

Patientâ??s refusal.

Patient with a known history of

-sensitivity and contraindications to drugs used

-chronic analgesic consumption

-psychiatric illness Patients non-euthyroid at the time of surgery.

Patients with known coagulopathy.

Infection at the site of block.

Patients with substernal goitre

Patients with stridor or respiratory compromise

Patients with thyroid malignancy requiring block dissection

Patients having advanced heart block

Patients with severe ventricular dysfunction, and/or hypovolemia

Patients with co-mobidities like diabetes mellitus or chronic hypertension

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Duration of postoperative analgesiaTimepoint: Around 1 year
Secondary Outcome Measures
NameTimeMethod
total consumption of analgesic in 24 hour <br/ ><br>post operative nausea vomiting <br/ ><br>adverse effects like hematoma, intra vascular injection, local anaesthetic toxicity, bradycardia, hypotension, sedation and post operative respiratory distressTimepoint: Around 1 year
© Copyright 2025. All Rights Reserved by MedPath